CD19-Targeted Immunotherapy Attenuates Vessel Wall Inflammation

被引：4
|
作者：
Derlin, Thorsten [1 ]
Koenecke, Christian [1 ]
Schultze-Florey, Christian [1 ]
Ganser, Arnold [1 ]
Bengel, Frank M. [1 ]
机构：
[1] Hannover Med Sch, Dept Nucl Med, Carl Neuberg Str 1, D-30625 Hannover, Germany
来源：
JACC-CARDIOVASCULAR IMAGING | 2021年 / 14卷 / 09期
关键词：
D O I：
10.1016/j.jcmg.2021.02.025
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1864 / 1866
页数：3
相关论文
共 50 条
  • [31] Clinicopathologic features of relapsed CD19(-) B-ALL in CD19-targeted immunotherapy: Biological insights into relapse and LILRB1 as a novel B-cell marker for CD19(-) B lymphoblasts
    Chen, Dong
    Fuda, Franklin
    Rosado, Flavia
    Saumell, Silvia
    John, Samuel
    Chen, Mingyi
    Koduru, Prasad
    Chen, Weina
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2024, 46 (03) : 503 - 509
  • [32] Clinicopathologic Features of Relapsed CD19(-) B-ALL in CD19-Targeted Immunotherapy: Insights Into Mechanism of Relapse and LILRB1 as a Novel B-cell Marker for CD19(-) B Lymphoblasts
    Chen, Dong
    Fuda, Franklin
    Rosado, Flavia
    Saumell, Silvia
    John, Samuel
    Koduru, Prasad
    Chen, Weina
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 930 - 930
  • [33] Fungal Infections Associated with CD19-Targeted Chimeric Antigen Receptor T Cell Therapy
    Charles Gaulin
    Zoey Harris
    Rich Kodama
    Monika Shah
    Janis Blair
    Yucai Wang
    Yi Lin
    Javier Muñoz
    Current Fungal Infection Reports, 2023, 17 : 87 - 97
  • [34] Fungal Infections Associated with CD19-Targeted Chimeric Antigen Receptor T Cell Therapy
    Gaulin, Charles
    Harris, Zoey
    Kodama, Rich
    Shah, Monika
    Blair, Janis
    Wang, Yucai
    Lin, Yi
    Munoz, Javier
    CURRENT FUNGAL INFECTION REPORTS, 2023, 17 (02) : 87 - 97
  • [35] Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells
    Joseph A. Fraietta
    Christopher L. Nobles
    Morgan A. Sammons
    Stefan Lundh
    Shannon A. Carty
    Tyler J. Reich
    Alexandria P. Cogdill
    Jennifer J. D. Morrissette
    Jamie E. DeNizio
    Shantan Reddy
    Young Hwang
    Mercy Gohil
    Irina Kulikovskaya
    Farzana Nazimuddin
    Minnal Gupta
    Fang Chen
    John K. Everett
    Katherine A. Alexander
    Enrique Lin-Shiao
    Marvin H. Gee
    Xiaojun Liu
    Regina M. Young
    David Ambrose
    Yan Wang
    Jun Xu
    Martha S. Jordan
    Katherine T. Marcucci
    Bruce L. Levine
    K. Christopher Garcia
    Yangbing Zhao
    Michael Kalos
    David L. Porter
    Rahul M. Kohli
    Simon F. Lacey
    Shelley L. Berger
    Frederic D. Bushman
    Carl H. June
    J. Joseph Melenhorst
    Nature, 2018, 558 : 307 - 312
  • [36] Extracellular Vesicles Expressing CD19 Antigen Improve Expansion and Efficacy of CD19-Targeted CAR-T Cells
    Zhang, Yuanyuan
    Ge, Tong
    Huang, Meijuan
    Qin, Yun
    Liu, Tianjiao
    Mu, Wei
    Wang, Gaoxiang
    Jiang, Lijun
    Li, Tongjuan
    Zhao, Lei
    Wang, Jue
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2023, 18 : 49 - 63
  • [37] Clinicopathologic Features of Relapsed CD19(-) B-ALL in CD19-Targeted Immunotherapy: Insights Into Mechanism of Relapse and LILRB1 as a Novel B-cell Marker for CD19(-) B Lymphoblasts
    Chen, Dong
    Fuda, Franklin
    Rosado, Flavia
    Saumell, Silvia
    John, Samuel
    Koduru, Prasad
    Chen, Weina
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 930 - 930
  • [38] Discovery of a novel genomic alteration that renders leukemic cells resistant to CD19-targeted immunotherapies
    Ghobadi, Armin
    Landmann, Jack H.
    Carter, Alun
    Cooper, Matthew L.
    Selli, Mehmet Emrah
    Chang, Jufang
    Baker, Matthew
    Miller, Christopher A.
    Ferraro, Francesca
    Chen, David Y.
    Smith, Amanda M.
    LaValle, Taylor A.
    Duncavage, Eric J.
    Chou, Justin
    Tam, Victor
    Benoun, Joseph M.
    Nater, Jenny
    Scholler, Nathalie
    Milletti, Francesca
    Vezan, Remus
    Bot, Adrian
    Rossi, John M.
    Singh, Nathan
    BLOOD ADVANCES, 2022, 6 (20) : 5634 - 5640
  • [39] Cerebral Spinal Fluid Parameters Following CD19-Targeted Therapies in Children and Young Adults
    Leib, Shiran
    Bielorai, Bella
    Vernitsky, Helly
    Aharony-Tevet, Yarden
    Toren, Amos
    Jacoby, Elad
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2024, 46 (01) : 29 - 32
  • [40] Novel CD19-targeted TriKE restores NK cell function and proliferative capacity in CLL
    Felices, Martin
    Kodal, Behiye
    Hinderlie, Peter
    Kaminski, Michael F.
    Cooley, Sarah
    Weisdorf, Daniel J.
    Vallera, Daniel A.
    Miller, Jeffrey S.
    Bachanova, Veronika
    BLOOD ADVANCES, 2019, 3 (06) : 897 - 907
12345